Inventor · disambiguated record
Michele C. Rizzolio
Also filed as: RIZZOLIO MICHELE C · RIZZOLIO MICHELE CATHERINE
16 granted patents·8 pending applications·131 citations·filing 1994–2021
93Inventor score
Files withJANSSEN PHARMACEUTICA NV12GLAXOSMITHKLINE LLC5GLOVER BOBBY NEAL2SMITHKLINE BEECHAM CORP2SYNTEX INC2
Top patents by PatentIndex Score
24 records- 0195US10487083B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 26, 2019·7 cites·12 claims
- 0295US10294226B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 21, 2019·11 cites·14 claims
- 0394US10364246B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 30, 2019·7 cites·9 claims
- 0493US11827638B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·2 cites·3 claims
- 0593US11059823B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·4 cites·37 claims
- 0691US10981911B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 20, 2021·6 cites·2 claims
- 0787US7714123B2Crystalline forms of an antiviral benzimidazole compoundGLAXOSMITHKLINE LLC·Filed 2007·Granted May 11, 2010·3 cites·1 claims
- 0883US9273034B2Meglumine salt formulations of 1-(5,6-dichloro-1H-benzo[D]imidazol-2-yl)-1H-pyrazole-4-carboxylic acidJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Mar 1, 2016·6 cites·3 claims
- 0980US7297683B2Crystalline forms of an antiviral benzimidazole compoundSMITHKLINE BEECHAM CORP·Filed 2001·Granted Nov 20, 2007·7 cites·8 claims
- 1079US5543408ACrystalline anhydrous mycophenolate mofetil and intravenous formulation thereofSYNTEX INC·Filed 1994·Granted Aug 6, 1996·37 cites·12 claims
- 1176US6469160B1Crystalline forms of an antiviral benzimidazole compoundSMITHKLINE BEECHAM CORP·Filed 1999·Granted Oct 22, 2002·24 cites·11 claims
- 1275US12202831B2Small molecule inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jan 21, 2025·0 cites·11 claims
- 1369US2018044366A1Novel crystalline forms of an antiviral benzimidazole compoundGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 1467US9163052B2Crystalline forms of an antiviral benzimidazole compoundGLOVER BOBBY NEAL·Filed 2011·Granted Oct 20, 2015·1 cites·16 claims
- 1564US10807969B2Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acidJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 20, 2020·0 cites·7 claims
- 1662US2017002035A1Novel crystalline forms of an antiviral benzimidazole compoundGLAXOSMITHKLINE LLC·Filed 2016·Application pending·0 cites
- 1761US2013261294A1Novel Crystalline Forms Of An Antiviral Benzimidazole CompoundGLAXOSMITHKLINE LLC·Filed 2013·Application pending·0 cites
- 1860US5545637AProcess for preparing pharmaceutical compositions containing crystalline anhydrous mycophenolate mofetil saltsSYNTEX INC·Filed 1995·Granted Aug 13, 1996·16 cites·9 claims
- 1958US2016030460A1Novel crystalline forms of an antiviral benzimidazole compoundGLAXOSMITHKLINE LLC·Filed 2015·Application pending·0 cites
- 2057US9708298B2Meglumine salt formulations of 1-(5,6-dichloro-1H-benzo[D]imidazol-2-yl)-1H-pyrazole-4-carboxylic acidJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 18, 2017·0 cites·4 claims
- 2155US2018201605A1Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acidJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2255US2011218338A12-aminopyrimidine modulators of the histamine h4 receptorJanseen Pharmaceutiacal NV·Filed 2011·Application pending·0 cites
- 2352US2020338051A1Non-clinical liquid formulations of pan-jak inhibitorJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 2449US2010179101A1Novel Crystalline Forms Of An Antiviral Benzimidazole CompoundGLOVER BOBBY NEAL·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →